Predicting orally disintegrating tablets formulations of ibuprophen tablets: An application of the new SeDeM-ODT expert system

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 3, 2012, Pages 638-648

  Aguilar Díaz, Johnny Edward ^a   García Montoya, Encarna ^b   Suñe Negre, José María ^b   Pérez Lozano, Pilar ^b   Miñarro, Montserrat ^b   Ticó, José Ramón ^b  

^a Manufacturing Science and Technology Manager   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bucodispersible tablets; Direct compression (DC); Disintegrant; IGCB; Preformulation; SeDeM ODT

Indexed keywords

AEROSIL; CARBOXYMETHYLCELLULOSE; CROSCARMELLOSE SODIUM; CROSPOVIDONE; CROSPOVIDONUM; DISINTEGRATING AGENT; EXCIPIENT; IBUPROFEN; MAGNESIUM STEARATE; MANNITOL; STARCH GLYCOLATE SODIUM; TALC; UNCLASSIFIED DRUG;

ARTICLE; DISPERSION; DRUG FORMULARY; DRUG SOLUBILITY; TABLET COMPRESSION; TABLET DISINTEGRATION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; EXCIPIENTS; EXPERT SYSTEMS; IBUPROFEN; POWDERS; TABLETS;

EID: 84858159960     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.12.012     Document Type: Article

References (35)

1. D. Berthoumieu, P. Trannoy, J.F. Cordoliani, A. Franois, J.M. Hédin, J. Lis, D. Damour, S. Chesnoy, and P. Lefvre Tabletting study for ODT's Manufacturing Chemist 2010 24 27
2. S. Bandari, R.K. Mittapalli, R. Gannu, and Y.M. Rao Orodispersible tablets: an overview Asian J. Pharm. 2 1 2008 2 11
3. S. Lindgren, and L. Janzon Dysphagia: prevalence of swallowing complaints and clinical finding Med. Clin. North. Am. 77 1993 3 5
4. S.V. Sastry, J.R. Nyshadham, and J.A. Fix Recent technological advances in oral drug delivery: a review Pharm. Sci. Technol. Today 3 2000 138 145 (Pubitemid 30195827)
5. Y. Fu, S. Yang, S.H. Jeong, S. Kimura, and K. Park Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies Crit. Rev. Ther. Drug. Carrier Syst. 21 2004 433 476
6. D.F. Fernandes Tavares, J.I. Espada García, C. Martín Sabroso, M.E. Gil Alegre, and A.I. Torres Suárez Comprimidos bucodispersables: ventajas terapéuticas y tecnológicas de elaboración Ars Pharm. 50 3 2009 153 167
7. Guidance for Industry: Orally Desintegrating Tablets: FDA. December 2008.
8. European Pharmacopeia, 7th ed., vol. 7.2, Council of Europe, Strasbourg (France), 2011, 01/2008:0478.
9. H. Seager Drug-delivery products and the Zydis fast-dissolving dosage form J. Pharm. Pharmacol. 50 1998 375 382 (Pubitemid 28197414)
10. W. Habib, R.K. Khankari, and J. Hontz Fast-dissolve drug delivery systems Crit. Rev. Ther. Drug. Carrier Syst. 17 2000 61 72 (Pubitemid 30174149)
11. L. Dobetti, Fast disintegrating tablets, US Patent 2003; 6: 596,311.
12. D. Brown Orally disintegrating tablets-taste over speed Drug. Del. Technol. 3 2003 58 61
13. K. Behnke, J. Sogaard, S. Martin, J. Bauml, A.V. Ravindran, and H. Agren Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study J. Clin. Psychopharmacol. 23 2003 358 364 (Pubitemid 36951177)
14. T.T. Jaccard, and J. Leyder Une nouvelle forme galenique le lyoc Ann. Pharm. FR. 43 1985 123 131 (Pubitemid 16245414)
15. G. Dollo, F. Chevanne, P. Le Corre, C. Chemtob, and R. Le Verge Bioavailability of phloroglucinol in man J. Pharm. Belg. 54 1999 75 82
16. E. Gafitanu, I. Dumistracel, and S. Antochi Formulations and bioavailability of propyphenazone in lyophilized tablets Rev. Med. Chir. Soc. Med. Nat. Iasi 95 1991 127 128
17. A. Clarke, F. Brewer, E.S. Johnson, N. Mallard, F. Hartig, and S. Taylor A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition J. Neural Transm. 110 2003 124 125
18. J.M. Suñé Negre, M. Roig Carreras, R. Fuster García, C. Hernández Pérez, R. Ruhí Roura, E. García Montoya, M. Miñarro Carmona, P. Pérez Lozano, and J.R. Ticó Grau Nueva metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: diagrama SeDeM Cien. Tecnol. Pharm. 3 2005 125 136 (Pubitemid 41578624)
19. Pilar Pérez, Josep M. Suñé-Negre, Montserrat Miñarro, Manel Roig, Roser Fuster, Encarna García-Montoya, Carmen Hernández, Ramón Ruhí, and Josep R. Ticó A new expert systems (SeDeM diagram) for control batch powder formulation and preformulation drug products Eur. J. Pharm. Biopharm. 64 3 2006 351 359 (Pubitemid 44585211)
20. J.M. Suñé Negre, P. Pérez Lozano, M. Miñarro Carmona, M. Roig Carreras, R. Fuster García, C. Hernández Pérez, R. Ruhí, E. García Montoya, and J.R. Ticó Grau Application of the SeDeM Diagram and new mathematical equation in the design of direct compression tablet formulation Eur. J. Pharm. Biopharm. 2008 1029 1039
21. J.E. Aguilar-Díaz, E. García-Montoya, P. Pérez-Lozano, J.M. Suñé-Negre, M. Miñarro, and J.R. Ticó The use of the SeDeM diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT Eur. J. Pharm. Biopharm. 73 2009 414 423
22. E. García Montoya, M. Suñé Negre, P. Pérez Lozano, M. Miñarro Carmona, M. Roig Carreras, and R.J.R. Ticó Grau Metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: diagrama SeDeM Farmespaña Ind., Enero./Feb. 2010 58 62
23. M. Suñé Negre, P. Pérez Lozano, M. Miñarro Carmona, M. Roig Carreras, R. Fuster García, C. Hernández Pérez, R. Ruhí, E. García Montoya, and J.R. Ticó Grau Optimization of parameters of the SeDeM diagram expert system: Hausner index (IH) and relative humidity (%RH) European Journal of Pharmaceutics and Biopharmaceutics 2011
24. The United States Pharmacopeia (USP 32 NF-27), 31 Revision. United States Pharmacopeial Convention, Inc. Rockville (MD), 2009; USP Monographs: 701, pp. 266.
25. European Pharmacopeia, 7th ed., vol. 7.2, Council of Europe, Strasbourg (France), 2011, 04/2011: 20901.
26. The United States Pharmacopeia (USP 31 NF-26), 31 Revision. United States Pharmacopeial Convention, Inc. Rockville (MD), 2008; USP Monographs:711.
27. The United States Pharmacopeia (USP 32 NF-27), 32 Revision. United States Pharmacopeial Convention, Inc. Rockville (MD), 2009; USP Monographs:Ibuprophen Tablets.
28. USP 32/NF 27, The United States Pharmacopeia, 32 Rev. and The National Formulary, 27th ed., United States Pharmacopoeial Convention, Inc. (Ed) Rockville, 2009; USP Monographs: 1217: Tablet Breaking Force.
29. European Pharmacopeia, 7th ed., vol. 7.2, Council of Europe, Strasbourg (France), 2011, 01/2008: 20908.
30. USP 32/NF 27, The United States Pharmacopeia, 32 rev and The National Formulary, 27th ed. United States Pharmacopoeial Convention, Inc. (Ed.), Rockville, 2009; USP Monographs: 1216: Tablet Friability.
31. European Pharmacopeia, 7th ed., vol. 7.2, Council of Europe, Strasbourg (France), 2011, 01/2010: 20907.
32. Handbook of Pharmaceutical Excipients, 5th ed., American Pharmaceutical Association. Electronical Edition. < http://www.medicinescomplete.com/mc/ excipients/current/1000307772.htm?q=%22primojel%22#-hit >, 2008 (visited 21.11.08).
33. P. Font Quer, Medicamenta, 6th ed., Editorial Labor. Barcelona, 1962, pp. 340-341.
34. M. Córdoba Borrego, J.M. Moreno Cerezo, M. Córdoba Díaz, and D. Córdoba Díaz Preformulación y desarrollo galénico de nuevas formulaciones por compresión directa con agentes hidrotrópicos Ind. Farm. 4 1996 65 70
35. L.W. Wong, and N. Pilpel The effect of particle shape on the mechanical properties of powders Int. J. Pharm. 59 1990 145 154 (Pubitemid 20088853)